These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27864544)

  • 1. From the Cover: Investigative Nonclinical Cardiovascular Safety and Toxicology Studies with BMS-986094, an NS5b RNA-Dependent RNA Polymerase Inhibitor.
    Gill M; Horn K; Hennan J; White R; Bounous D; Clark S; Megill JR; Janovitz E; Davies M; Sanderson T; Graziano M
    Toxicol Sci; 2017 Feb; 155(2):348-362. PubMed ID: 27864544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and Function.
    Baumgart BR; Wang F; Kwagh J; Storck C; Euler C; Fuller M; Simic D; Sharma S; Arnold JJ; Cameron CE; Van Vleet TR; Flint O; Bunch RT; Davies MH; Graziano MJ; Sanderson TP
    Toxicol Sci; 2016 Oct; 153(2):396-408. PubMed ID: 27466212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single- and repeat-dose toxicity of IDX14184, a nucleotide prodrug with antiviral activity for hepatitis C viral infection, in mice, rats, and monkeys.
    Luo S; Rush R; Standring D
    Hum Exp Toxicol; 2016 May; 35(5):472-90. PubMed ID: 26138064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside.
    Uchino H; Fujishima J; Fukuoka K; Iwakiri T; Kamikuri A; Maeda H; Nakama K
    J Toxicol Sci; 2017; 42(5):629-640. PubMed ID: 28904298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclinical Safety Profile of BMS-986001, a Nucleoside Transcriptase Inhibitor for Combination Retroviral Therapy.
    Mausumee G; Frank S; Shawn C; Dara H; Zhao Y; Soleil PM; Sanderson TP; Michael G; Marc D
    Int J Toxicol; 2014 May; 33(3):204-218. PubMed ID: 24846376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C.
    Ahmad T; Yin P; Saffitz J; Pockros PJ; Lalezari J; Shiffman M; Freilich B; Zamparo J; Brown K; Dimitrova D; Kumar M; Manion D; Heath-Chiozzi M; Wolf R; Hughes E; Muir AJ; Hernandez AF
    Hepatology; 2015 Aug; 62(2):409-16. PubMed ID: 25251156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase.
    Rigat KL; Lu H; Wang YK; Argyrou A; Fanslau C; Beno B; Wang Y; Marcinkeviciene J; Ding M; Gentles RG; Gao M; Abell LM; Roberts SB
    J Biol Chem; 2014 Nov; 289(48):33456-68. PubMed ID: 25301950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Metabolite Formation in Human Hepatocytes and Cardiomyocytes and Metabolism and Tissue Distribution in Monkeys of the 2'-C-Methylguanosine Prodrug BMS-986094 : Potential Role in Clinical Cardiovascular Toxicity.
    Li W; Trouba KJ; Ma L; Kwagh J; Storck C; Zhu Y; Flint O; Humphreys WG; Wang J; Liu A; Wang B; Graziano MJ; Davies MH; Sanderson TP
    Int J Toxicol; 2017; 36(1):35-49. PubMed ID: 28056568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Potent Pan-TGFβ Neutralizing Monoclonal Antibody Elicits Cardiovascular Toxicity in Mice and Cynomolgus Monkeys.
    Mitra MS; Lancaster K; Adedeji AO; Palanisamy GS; Dave RA; Zhong F; Holdren MS; Turley SJ; Liang WC; Wu Y; Meng YG; Vernes JM; Schutten MM
    Toxicol Sci; 2020 May; 175(1):24-34. PubMed ID: 32077954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection.
    Sims KD; Lemm J; Eley T; Liu M; Berglind A; Sherman D; Lawitz E; Vutikullird AB; Tebas P; Gao M; Pasquinelli C; Grasela DM
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3496-503. PubMed ID: 24733462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
    Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymerase.
    Lemm JA; Liu M; Gentles RG; Ding M; Voss S; Pelosi LA; Wang YK; Rigat KL; Mosure KW; Bender JA; Knipe JO; Colonno R; Meanwell NA; Kadow JF; Santone KS; Roberts SB; Gao M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3485-95. PubMed ID: 24733465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys.
    Chen Y; Dale Thurman J; Kinter LB; Bialecki R; Eric McDuffie J
    Toxicol Appl Pharmacol; 2017 Dec; 336():66-74. PubMed ID: 29051111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice.
    Shi N; Hiraga N; Imamura M; Hayes CN; Zhang Y; Kosaka K; Okazaki A; Murakami E; Tsuge M; Abe H; Aikata H; Takahashi S; Ochi H; Tateno-Mukaidani C; Yoshizato K; Matsui H; Kanai A; Inaba T; McPhee F; Gao M; Chayama K
    Gut; 2013 Jul; 62(7):1055-61. PubMed ID: 23322441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase.
    Zheng BZ; D'Andrea SV; Hanumegowda U; Knipe JO; Mosure K; Zhuo X; Lemm JA; Liu M; Rigat KL; Wang YK; Fang H; Poronsky C; Cutrone J; Wu DR; Arunachalam PN; Balapragalathan TJ; Arumugam A; Mathur A; Meanwell NA; Gao M; Roberts SB; Kadow JF
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3294-3300. PubMed ID: 28633899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.
    Gautier JC; Zhou X; Yang Y; Gury T; Qu Z; Palazzi X; Léonard JF; Slaoui M; Veeranagouda Y; Guizon I; Boitier E; Filali-Ansary A; van den Berg BHJ; Poetz O; Joos T; Zhang T; Wang J; Detilleux P; Li B
    Toxicol Appl Pharmacol; 2016 Jul; 303():1-10. PubMed ID: 27105553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cardiac function in unrestrained dogs and monkeys using left ventricular dP/dt.
    Buchanan LV; Warner WA; Arthur SR; Gleason CR; Lewen G; Levesque PC; Gill MW
    J Pharmacol Toxicol Methods; 2016; 80():51-8. PubMed ID: 27063376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes.
    Yanagida S; Satsuka A; Hayashi S; Ono A; Kanda Y
    J Toxicol Sci; 2021; 46(8):359-369. PubMed ID: 34334557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus.
    Feng JY; Xu Y; Barauskas O; Perry JK; Ahmadyar S; Stepan G; Yu H; Babusis D; Park Y; McCutcheon K; Perron M; Schultz BE; Sakowicz R; Ray AS
    Antimicrob Agents Chemother; 2016 Feb; 60(2):806-17. PubMed ID: 26596942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MS.
    Liu A; Lute J; Gu H; Wang B; Trouba KJ; Arnold ME; Aubry AF; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():29-40. PubMed ID: 26209768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.